Low-Dose Hsp90 Inhibitors Tumor-Selectively Sensitize Bladder Cancer Cells to Chemoradiotherapy

Cell Cycle - United States
doi 10.4161/cc.10.24.18616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Mesenchymal Stem Cells and Carcinoma-Associated Fibroblasts Sensitize Breast Cancer Cells in 3D Cultures to Kinase Inhibitors

International Journal of Oncology
Cancer ResearchOncology
2011English

Ginkgo May Sensitize Ovarian Cancer Cells to Cisplatin

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2012English

Effective Treatment of Anal Cancer in the Elderly With Low-Dose Chemoradiotherapy

British Journal of Cancer
Cancer ResearchOncology
2005English

MicroRNA 9-3p Targets 1 Integrin to Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection

PLoS ONE
Multidisciplinary
2014English

Peptide Fragments of Hsp70 Modulate Its Chaperone Activity and Sensitize Tumor Cells to Anti-Cancer Drugs

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
1995English

Targeting HSF1 Sensitizes Cancer Cells to HSP90 Inhibition

Oncotarget
Oncology
2013English

Sensitization of Multidrug-Resistant Cancer Cells to Hsp90 Inhibitors by NSAIDs-induced Apoptotic and Autophagic Cell Death

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy